TJ brings 25 years of experience in pharmaceutical operations and leadership roles within the CDMO/CMO marketplace. As an owner/entrepreneur of Powdersize, Inc growing it to its eventual exit to Capsugel (2015), TJ has become a thought contributor in the bioavailability enhancement space focused on particle size control technologies including classification/milling/micronization. More recently, TJ has returned as CEO to lead Microsize, following the divestiture from Lonza (2022). Microsize is a leading independently owned contract micronization facility for the pharmaceutical industry within the US.